Home > Insider Trading > Merck Sharp & Dohme Corp.

Merck Sharp & Dohme Corp. (MRK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

10 Cheap Pharmaceutical Stocks to Buy According to Analysts

Almost no other industry goes as far as the phrase "defensive" as the healthcare sector, which encompasses a wide range of companies that provide patient care, research and development of new medicines...

Keep Reading →

February 22nd, 2025 - Hedge Funds News

11 Most Expensive Stocks Insiders Are Buying Recently

The broader market returned around 21% over the past 12 months, and it is also doing well this year. Since the beginning of the year, it has moved 3.45%.

Keep Reading →

February 21st, 2025 - Insider Trading News

13 Cheap High Dividend Stocks To Invest In Now

According to Deutsche Bank Wealth Management, the global economy in 2025 is expected to face some tough challenges, with growth forecasts looking modest – the US GDP at 2.0%, the Eurozone at 0.9%, and...

Keep Reading →

February 18th, 2025 - Dividend Stocks Hedge Funds News

10 Best Very Cheap Stocks To Buy Right Now

The stock market had a mixed start to 2025 as the Chinese Deepseek AI model has put the U.S. AI giants on the back foot.

Keep Reading →

February 17th, 2025 - Hedge Funds News

10 Best Drug Stocks to Buy Now

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.

Keep Reading →

February 16th, 2025 - Hedge Funds Industries News

10 Most Oversold S&P 500 Stocks in 2024

Strong economic growth and the prospect of declining interest rates continue to support gains in global equities.

Keep Reading →

February 15th, 2025 - Hedge Funds News

Jim Cramer Discusses These 11 Stocks & Finds Few Reasons To Sell

In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on why the flagship S&P index remained stable despite multiple catalysts such as a trade war, DeepSeek, and a new administration...

Keep Reading →

February 15th, 2025 - News

Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc.

Keep Reading →

February 13th, 2025 - News Stock Analysis

Why These 10 Dividend Stocks Are Declining?

Companies that pay dividends have been a reliable choice for investors seeking a passive and somewhat stable income.

Keep Reading →

February 12th, 2025 - News

Jim Cramer Discusses These 10 Stocks & An Outfit Better Than DeepSeek

In his recent appearance on CNBC's Squawk on the Street, Jim Cramer spent nearly all of the show either discussing stocks or the changed environment for AI data center stocks after the DeepSeek selloff...

Keep Reading →

February 11th, 2025 - News